Family Office Briefing on research bySavills·Feb 7, 2025
New York Q4 2024 Life Sciences Market Overview
New York life sciences venture funding surged nearly 70% in 2024 — family offices should consider co-GP opportunities with innovative operators.
Key Metrics
| Metric | Value |
|---|---|
| Venture Capital Funding Growth | 70.0% |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Savills
Building a thesis around New York? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.